Muhannad Abu-Remaileh, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Oxidoreductases | 5 | 2015 | 424 | 1.180 |
Why?
|
Tumor Suppressor Proteins | 7 | 2022 | 2849 | 0.960 |
Why?
|
Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2018 | 627 | 0.480 |
Why?
|
Cells | 1 | 2014 | 168 | 0.460 |
Why?
|
Glucose | 2 | 2019 | 4397 | 0.340 |
Why?
|
Central Nervous System | 1 | 2015 | 1357 | 0.310 |
Why?
|
Carcinoma, Hepatocellular | 1 | 2018 | 2214 | 0.270 |
Why?
|
Genes, Tumor Suppressor | 2 | 2022 | 1097 | 0.240 |
Why?
|
Liver Neoplasms | 1 | 2018 | 4253 | 0.210 |
Why?
|
Gene Expression Regulation, Neoplastic | 1 | 2018 | 8428 | 0.210 |
Why?
|
Mice, Knockout | 5 | 2019 | 14557 | 0.180 |
Why?
|
Diethylnitrosamine | 1 | 2018 | 38 | 0.160 |
Why?
|
Carbohydrate Metabolism | 1 | 2019 | 264 | 0.150 |
Why?
|
Neoplasms | 3 | 2015 | 21683 | 0.150 |
Why?
|
Digoxin | 1 | 2018 | 250 | 0.150 |
Why?
|
Chromosome Fragile Sites | 1 | 2014 | 27 | 0.130 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2019 | 11725 | 0.130 |
Why?
|
Genetic Engineering | 1 | 2019 | 951 | 0.110 |
Why?
|
Mice, Inbred C57BL | 4 | 2019 | 21827 | 0.110 |
Why?
|
Steroids | 2 | 2014 | 930 | 0.110 |
Why?
|
Tumor Burden | 1 | 2018 | 1915 | 0.100 |
Why?
|
Hepatocytes | 1 | 2018 | 1211 | 0.100 |
Why?
|
Cholesterol, HDL | 2 | 2014 | 1814 | 0.100 |
Why?
|
Lymphatic Metastasis | 1 | 2018 | 2924 | 0.090 |
Why?
|
Genomic Instability | 1 | 2014 | 695 | 0.090 |
Why?
|
Lipoproteins, HDL | 1 | 2014 | 638 | 0.090 |
Why?
|
Mice | 6 | 2022 | 81183 | 0.090 |
Why?
|
Protein Structure, Tertiary | 1 | 2015 | 3846 | 0.080 |
Why?
|
Animals | 8 | 2022 | 168757 | 0.080 |
Why?
|
Disease Models, Animal | 2 | 2018 | 18029 | 0.080 |
Why?
|
Mice, Transgenic | 1 | 2019 | 9734 | 0.070 |
Why?
|
Mitochondria | 1 | 2019 | 3520 | 0.070 |
Why?
|
Lipid Metabolism | 1 | 2014 | 1889 | 0.070 |
Why?
|
Pancreatic Neoplasms | 1 | 2022 | 5256 | 0.060 |
Why?
|
Liver | 2 | 2018 | 7474 | 0.060 |
Why?
|
Cell Transformation, Neoplastic | 1 | 2014 | 2942 | 0.060 |
Why?
|
Bone and Bones | 1 | 2014 | 2575 | 0.060 |
Why?
|
Muscle, Skeletal | 1 | 2019 | 4931 | 0.060 |
Why?
|
Cell Proliferation | 1 | 2018 | 10481 | 0.050 |
Why?
|
Cell Line, Tumor | 1 | 2018 | 16689 | 0.050 |
Why?
|
Bone Morphogenetic Protein 2 | 1 | 2022 | 350 | 0.050 |
Why?
|
Disease Progression | 1 | 2014 | 13284 | 0.040 |
Why?
|
Signal Transduction | 2 | 2018 | 23403 | 0.040 |
Why?
|
Prognosis | 1 | 2018 | 29063 | 0.040 |
Why?
|
Transforming Growth Factor beta | 1 | 2022 | 2007 | 0.030 |
Why?
|
Angiopoietins | 1 | 2014 | 80 | 0.030 |
Why?
|
Apolipoprotein A-I | 1 | 2014 | 281 | 0.030 |
Why?
|
Male | 4 | 2019 | 350118 | 0.030 |
Why?
|
Calcification, Physiologic | 1 | 2013 | 169 | 0.030 |
Why?
|
Chromosomes, Human, Pair 16 | 1 | 2014 | 354 | 0.030 |
Why?
|
Lipase | 1 | 2014 | 314 | 0.030 |
Why?
|
Humans | 7 | 2022 | 744343 | 0.030 |
Why?
|
Gene Targeting | 1 | 2013 | 880 | 0.020 |
Why?
|
Haplotypes | 1 | 2014 | 2779 | 0.020 |
Why?
|
Osteosarcoma | 1 | 2013 | 881 | 0.020 |
Why?
|
Models, Animal | 1 | 2013 | 2171 | 0.020 |
Why?
|
Triglycerides | 1 | 2014 | 2454 | 0.020 |
Why?
|
Up-Regulation | 1 | 2014 | 4217 | 0.020 |
Why?
|
Alleles | 1 | 2014 | 6933 | 0.010 |
Why?
|
Sequence Analysis, DNA | 1 | 2014 | 4803 | 0.010 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2013 | 3617 | 0.010 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2014 | 3597 | 0.010 |
Why?
|
Phenotype | 1 | 2013 | 16365 | 0.010 |
Why?
|
Polymorphism, Single Nucleotide | 1 | 2014 | 15519 | 0.010 |
Why?
|
Adolescent | 1 | 2014 | 85781 | 0.000 |
Why?
|
Female | 2 | 2014 | 380194 | 0.000 |
Why?
|
Aged | 1 | 2014 | 163280 | 0.000 |
Why?
|
Middle Aged | 1 | 2014 | 213383 | 0.000 |
Why?
|
Adult | 1 | 2014 | 214055 | 0.000 |
Why?
|